Intravenous selenium supplementation in the form of sodium selenite to critically ill patients with ARDS showed replenished selenium status, restored the antioxidant capacity of the lungs, and moderated inflammatory responses suppressing IL-1β and IL-6 levels. This evidence concerns the gene IL1B and acute respiratory distress syndrome.